Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.

Diana Wouters1, Hans D Wiessenberg, Margreet Hart

  • 1Department of Immunopathology, Sanquin Research and Laboratory for Experimental and Clinical Immunology, Academic Medical Centre, Amsterdam, Netherlands. d.wouters@sanquin.nl

Journal of Immunological Methods
|April 26, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026
Same author

Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibody.

mAbs·2026
Same author

Development of an anti-rat complement C2 antibody that improves renal outcome in a rat kidney transplant model.

Frontiers in immunology·2026
Same author

Association of Carboxypeptidase B2 Gene Polymorphisms With Graft Loss in Kidney Transplantation.

Transplantation direct·2026
Same author

IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Alternative pathway-mediated tubular complement activation in human proteinuric kidney diseases: a proof-of-concept study.

Clinical kidney journal·2025

New markers, C1q-C4 and C1q-C3 complexes, specifically indicate classical complement pathway activation. These findings offer a more precise method for assessing complement system activity in various conditions.

Area of Science:

  • Immunology
  • Complement System Biology

Background:

  • Classical complement pathway activation is typically assessed by measuring activated C4 levels.
  • Current methods lack specificity, failing to distinguish between classical and lectin pathway activation.

Purpose of the Study:

  • To identify specific biomarkers for classical complement pathway activation.
  • To investigate the formation of C1q-C4 and C1q-C3 complexes as potential markers.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was employed to detect C1q-complement complexes.
  • In vitro experiments involved activating complement pathways using various stimuli.
  • Plasma samples from patients undergoing cardiopulmonary bypass surgery and suffering from rheumatoid arthritis were analyzed.

Related Experiment Videos

Main Results:

  • C1q-C3d/C4d complexes were specifically generated during classical pathway activation in vitro, excluding alternative or lectin pathway involvement.
  • Levels of C1q-C4 complexes were significantly elevated in patients undergoing cardiopulmonary bypass surgery and those with rheumatoid arthritis compared to healthy individuals.
  • The presence of these complexes was not affected by repeated freezing and thawing.

Conclusions:

  • Complexes formed between C1q and C4 or C3 are specific indicators of classical complement pathway activation.
  • These novel complexes offer a more precise diagnostic tool for evaluating classical pathway activity.
  • The findings have implications for understanding and diagnosing complement-mediated diseases.